There is evidence that the number of IFN-γ-producing lymphocytes is increased in the lungs of COPD patients [43], IFN-γ levels are raised in the airways of COPD patients, and IFN-γ signaling is increased in the lungs of COPD patients [44]. This evidence concerns the gene IFNG and chronic obstructive pulmonary disease.